UNSPSC 41131501: Automated cell counter

In this classification, an automated cell counter is a fully-automated or semi-automated device used to count red blood cells, white blood cells, or blood platelets using a sample of the patient's peripheral blood (blood circulating in one of the body's extremities, such as the arm). US FDA regulates Automated cell counter under 21 CFR 864.5200 and under FDA product code GKL.

UNSPSC 41131501 Automated cell counter is a Commodity code representing laboratory diagnostic equipment and consumables for clinical hematology and blood analysis. State and local governments are procuring specialized analyzers, proficiency testing samples, and instrument-specific consumables used in hemoglobin screening, blood chemistry analysis, and lead detection at public health laboratories, state health departments, and university research facilities. Recent solicitations show demand for ion-exchange HPLC systems with automated sample-loading capability, custom-manufactured proficiency testing materials for quality assurance, and replacement parts and supplies for PerkinElmer ICP-MS instruments. The issuing bodies are primarily state health and human services departments—specifically the Texas Health and Human Services Commission and Department of State Health Services—alongside higher-education institutions such as the University of Wisconsin-Madison. No dedicated set-aside designations appear in the recent opportunities, though HUB subcontracting plans are encouraged in some cases.

Activity concentrates in Texas and Wisconsin based on recent postings. The Texas Health and Human Services Commission has issued two IFBs within the past four months: HHS0017310 for a D-10 Hemoglobin Testing System with Rack Loader (due May 18, 2026) to replace equipment at the South Texas Lab in Harlingen, and HHS0017071 for PerkinElmer ICP-MS consumables and supplies (due March 5, 2026) supporting pediatric blood lead screening across HHSC and DSHS. The University of Wisconsin-Madison posted ShopUW+ Event 2026-UWMSN-01287-RFB for custom-made hematology and whole blood chemistry proficiency testing samples (due May 5, 2026). Historical spend guidance for similar goods ranges from $20,000 to $80,000 annually. Firm fixed pricing is required; awards are made on best-value rather than lowest-price basis; and contracts typically run through August 31, 2026, with one-year extension options at the agency's sole discretion. All contracts remain subject to appropriations and fund availability with no volume guarantees to vendors.